Clinical Trial Update: A Study to Determine if the Drug, Pyrvinium Pamoate, is Safe and Tolerable in Patients With Pancreatic Cancer [Phase 1]

View source ↗

Summary

This document updates the status of a Phase 1 trial evaluating Pyrvinium Pamoate for safety and tolerability in pancreatic cancer. The study is currently active…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer
• Pancreatic Ductal Adenocarcinoma

Drugs mentioned

• Pyrvinium Pamoate (pyrvinium pamoate)

Snippet

Sponsor: Thomas Jefferson University | Conditions: Resectable Pancreatic Ductal Adenocarcinoma, Stage 0 Pancreatic Cancer AJCC v8 | Phase 1 | Status: ACTIVE_NOT_RECRUITING